The gene encoding the melanin-concentrating hormone receptor 1 is associated with schizophrenia in a Danish case–control sample

Objective The MCHR1 gene encoding the melanin-concentrating hormone receptor 1 is located on chromosome 22q13.2 and has previously been associated with schizophrenia in a study of cases and controls from the Faroe Islands and Scotland. Herein we report an association between variations in the MCHR1 gene and schizophrenia, based on analyses of a larger sample and an increased number of single nucleotide polymorphisms (SNPs) than used in the previous study. Methods Eighteen SNPs in the MCHR1 gene region were genotyped in a Caucasian case–control sample from Denmark consisting of 390 individuals with schizophrenia and 814 control individuals. Sex-specific analysis and analysis of association with antipsychotic treatment were performed. Results Five SNPs in the proximal region of MCHR1 were significantly associated with schizophrenia. The associations seemed to be sex specific, predominantly seen in men where one SNP (rs133073) remained significant (P=0.003) after correction for multiple testing. When combining the P values in the proximal region of MCHR1, the region-wise P value was low (P=0.009) supporting that variations in this part of the gene is associated with schizophrenia. Furthermore, the association was stronger in patients responding to conventional and atypical antipsychotic medication except clozapine. Conclusion Our results suggest that MCHR1 may influence schizophrenia susceptibility, in particular among men and patients responding to conventional (nonclozapine) treatment.

[1]  M. Swami.  New from NPG: Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Medicine.

[2]  S. Purcell,et al.  Support of association between BRD1 and both schizophrenia and bipolar affective disorder , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  D. Richard,et al.  Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance , 2010, Behavioural Brain Research.

[4]  Peter N. Murakami,et al.  Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder , 2009, Schizophrenia Research.

[5]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[6]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[7]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[8]  Xia Li,et al.  Preclinical Evaluation of Melanin-Concentrating Hormone Receptor 1 Antagonism for the Treatment of Obesity and Depression , 2009, Journal of Pharmacology and Experimental Therapeutics.

[9]  M. Millan,et al.  The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats. , 2008, International Journal of Neuropsychopharmacology.

[10]  A. Fagan,et al.  Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder , 2008, Molecular Psychiatry.

[11]  Douglas R. Porter,et al.  Dysregulation of the Mesolimbic Dopamine System and Reward in MCH−/− Mice , 2008, Biological Psychiatry.

[12]  W. Honer,et al.  A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia , 2008, Psychiatric genetics.

[13]  D. Blackwood,et al.  Homozygosity mapping in a family presenting with schizophrenia, epilepsy and hearing impairment , 2008, European Journal of Human Genetics.

[14]  Philip S Rosenberg,et al.  PGA: power calculator for case-control genetic association analyses , 2008, BMC Genetics.

[15]  H. Fukuyama,et al.  Structural abnormalities of the adhesio interthalamica and mediodorsal nuclei of the thalamus in schizophrenia , 2008, Schizophrenia Research.

[16]  Vladimir I. Vladimirov,et al.  AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families , 2008, Biological Psychiatry.

[17]  D. Rujescu,et al.  Strong evidence that GNB1L is associated with schizophrenia. , 2008, Human molecular genetics.

[18]  Tao Li,et al.  Genome-Wide Association Identifies a Common Variant in the Reelin Gene That Increases the Risk of Schizophrenia Only in Women , 2008, PLoS genetics.

[19]  H. Shin,et al.  Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population , 2007, Schizophrenia Research.

[20]  Holly Neibergs,et al.  Evidence for two schizophrenia susceptibility genes on chromosome 22q13 , 2007, Psychiatric genetics.

[21]  Patrick F. Sullivan,et al.  Spurious Genetic Associations , 2007, Biological Psychiatry.

[22]  C. Swanson,et al.  Efficacy of the MCHR1 Antagonist N-[3-(1-{[4-(3,4-Difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in Mouse Models of Anxiety and Depression following Acute and Chronic Administration Is Independent of Hippocampal Neurogenesis , 2007, Journal of Pharmacology and Experimental Therapeutics.

[23]  Eden R Martin,et al.  No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.

[24]  Madhuri Roy,et al.  A Study of the Involvement of Melanin-Concentrating Hormone Receptor 1 (MCHR1) in Murine Models of Depression , 2007, Biological Psychiatry.

[25]  K. D. Jakobsen,et al.  Diagnostic Agreement of Schizophrenia Spectrum Disorders among Chronic Patients with Functional Psychoses , 2006, Psychopathology.

[26]  T. Hansen,et al.  Apolipoprotein D is associated with long-term outcome in patients with schizophrenia , 2006, The Pharmacogenomics Journal.

[27]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[28]  Y. Teo,et al.  Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. , 2005, Brain research. Molecular brain research.

[29]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[30]  K. Huse,et al.  Mutation analysis of the MCHR1 gene in human obesity. , 2005, European journal of endocrinology.

[31]  Shigeru Okuyama,et al.  Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists , 2005, Journal of Pharmacology and Experimental Therapeutics.

[32]  A. Adamantidis,et al.  Disrupting the melanin‐concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function , 2005, The European journal of neuroscience.

[33]  Robert M Sears,et al.  The Hypothalamic Neuropeptide Melanin-Concentrating Hormone Acts in the Nucleus Accumbens to Modulate Feeding Behavior and Forced-Swim Performance , 2005, The Journal of Neuroscience.

[34]  S. Faraone,et al.  Genome-wide scan of homogeneous subtypes of NIMH genetics initiative schizophrenia families , 2005, Psychiatry Research.

[35]  E. Tzavara,et al.  Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice , 2005, The Journal of Neuroscience.

[36]  S. Schneider,et al.  Arlequin (version 3.0): An integrated software package for population genetics data analysis , 2005, Evolutionary bioinformatics online.

[37]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[38]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[39]  O. Mors,et al.  Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. , 2002, American journal of medical genetics.

[40]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E Stern,et al.  Mesolimbic Activity Associated with Psychosis in Schizophrenia: Symptom‐specific PET Studies , 1999, Annals of the New York Academy of Sciences.

[42]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[43]  M. Kendall.  Statistical Methods for Research Workers , 1937, Nature.